Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 572835Generated: October 30, 2026

HCID 56947871, compound → HCID 56948114, compound

https://huagongshe.com/reaction/572835

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 56947871HCID 56947871—
ReactantHCID 178418265HCID 178418265—
SolventDiethyl EtherHCID 3283—
SolventTetrahydrofuranHCID 8028—
SolventN-methyl-2-pyrrolidoneHCID 13387—
ProductHCID 56948114HCID 56948114—

Reaction Conditions

Temperature0 °C

Reaction Steps

To a mixture of trifluoromethanesulfonic acid 3-[benzothiazol-2-yl(1-methylpiperidin-4-yloxy)methyl]phenyl ester (110 mg) and ferric acetylacetonate (4 mg) in a mixture of tetrahydrofurane (4.5 mL) and N-methylpyrrolidone (0.25 mL) cooled at 0° C. is added a 2M solution of butylmagnesium chloride in tetrahydrofurane (150 μL). The mixture is stirred at room temperature for 25 min, then warmed at 30° C. for 15 min. A second addition of butylmagnesium chloride in tetrahydrofurane (150 μL) is performed. The mixture is then diluted with diethyl ether and quenched with 0.5N hydrochloric solution. The aqueous phase is extracted with diethyl ether, then ethyl acetate. Organic phases are pooled, dried over magnesium sulfate and concentrated under reduced pressure. The residue is purified by chromatography (gradient heptane/ethyl acetate from 99/1 to 90/10). The product is then refluxed in methanol and concentrated to give 2-[(3-butylphenyl)(1-methylpiperidin-4-yloxy)methyl]benzothiazole.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09029357B2
Source datasetuspto-grants-2015_05
ORD IDord-780a03d64a8e4de3bf5a863486241212
Source noteuspto-grants-2015_05